Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Dechêne

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Colorectal Cancer|March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal CancerMarcel Wiesweg, Henning Reis, Tobias Köster, et al.
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitisSvenja Sydor, Paul Manka, Lea van Buren, et al.
Future Oncology (London, England)|January 27, 2022
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocolNajib Ben Khaled, Max Seidensticker, Jens Ricke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
Cancers|October 14, 2022
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisCatherine Leyh, Niklas Heucke, Clemens Schotten, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2013
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterMarcel Wiesweg, Saskia Ting, Henning Reis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Colorectal Cancer|March 13, 2018
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal CancerMarcel Wiesweg, Henning Reis, Tobias Köster, et al.
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitisSvenja Sydor, Paul Manka, Lea van Buren, et al.
Future Oncology (London, England)|January 27, 2022
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocolNajib Ben Khaled, Max Seidensticker, Jens Ricke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
Cancers|October 14, 2022
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisCatherine Leyh, Niklas Heucke, Clemens Schotten, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2013
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterMarcel Wiesweg, Saskia Ting, Henning Reis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
Pageof 6